Rhumbline Advisers Atossa Therapeutics, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 122,218 shares of ATOS stock, worth $108,774. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,218
Previous 123,039
0.67%
Holding current value
$108,774
Previous $187,000
39.04%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATOS
# of Institutions
88Shares Held
26.5MCall Options Held
466KPut Options Held
91.8K-
Black Rock Inc. New York, NY9.2MShares$8.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$5.87 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.81MShares$2.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.31MShares$1.17 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $113M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...